🛏 Sheela Foam Q2FY26 — The Great Indian Mattress War: ₹875 Cr Sales, ₹14 Cr Profit & 1,436 Cr Debt (Because Comfort Costs Money)
1. At a Glance
Welcome to the land where “Sleepwell” is not just a mattress but a lifestyle, and Sheela Foam Ltd (NSE: SFL | BSE: 540203) is the brand that literally wants India to rest easy — even if its own balance sheet can’t.
For Q2FY26, the foam giant reported Revenue ₹875 crore, PAT ₹14.4 crore, and an OPM of 9.96%. That’s decent on paper until you notice the 27.8% YoY decline in profit and a P/E ratio of 127x, which is roughly the same as an Ambien overdose for valuation sense.
With a market cap of ₹7,797 crore and ROE of 2%, Sheela Foam is making more mattresses than money. Debt ballooned from ₹466 crore in FY24 to a soft-yet-suffocating ₹1,436 crore in FY25, thanks to acquisitions of Kurlon and Furlenco, the corporate equivalent of adding a sofa and a bean bag to a bed and calling it “synergy.”
But to give credit (and debt) where due, Sheela Foam now controls India’s largest mattress empire — Sleepwell + Kurlon + Furlenco, commanding nearly 30% of the Indian market and 40% in Australia through Joyce Foam.
At ₹717 a share, this is a company that sells comfort to the country — but clearly, investors aren’t sleeping easy yet.
2. Introduction – The Foamfather Saga
Once upon a springy time, in 1971, a company decided that Indians deserved more than coir and cotton. Five decades later, Sheela Foam Ltd runs a kingdom of polyurethane, pillows, and patience.
Its flagship brand Sleepwell is to mattresses what Parle-G is to biscuits — omnipresent, nostalgic, and still slightly overpriced. Add to that the acquisition of Kurlon (India’s original “good night” brand) and Furlenco, the hip furniture startup for millennials who move every six months, and you’ve got a portfolio stretching from old-school uncles to Instagram couples.
Yet, despite its consumer dominance, Sheela’s financials look like a half-inflated airbed. Revenues are rising at a sleepy 5% CAGR, while profits have fallen 43% YoY. Margins are thinner than a budget bedsheet.
Why? Because consolidation is expensive, and foam doesn’t scale like software. Raw material prices (especially TDI and polyols) have been volatile, freight costs still haunt them, and post-merger integration costs from Kurlon and Furlenco are biting harder than a spring mattress in May.
Still, this is the company that taught India to sleep better — even if investors are now losing sleep over the debt load.
3. Business Model – WTF Do They Even Do?
Sheela Foam doesn’t just sell mattresses — it sells peace of mind with a finance charge.
Here’s their 3-layered mattress of a business:
Mattresses (49% of revenue) – The Sleepwell and Kurlon brands dominate India’s organized market. From orthopaedic to spring to “Cool Gel,” they’ve got a product for every backache and breakup.
Technical Foam (20%) – Used in cars, furniture, filters, and acoustics — the unsung hero of Sheela’s stable.
Furniture & Comfort Foam (8%) – Cushioning for homes, sofas, and the occasional boss’s chair.
Others (23%) – Includes exports and niche foam products across Australia, Spain, and a tiny IT arm called STAQO, probably for people who prefer debugging over sleeping.
Their international footprint includes 24 manufacturing plants across India, Spain, and Australia with a combined capacity of 1,87,000 MTPA — or enough foam to wrap the entire Delhi NCR in comfort (which some people might say it deserves).
They’ve also gone aggressively retail — over 10,000 multi-brand outlets and 6,000 exclusive brand stores, up from 4,400 in FY22. Clearly, they’re trying to turn mattresses into a lifestyle statement — not just a necessity you buy once a decade.
But consolidation fatigue is real. The acquisition of Kurlon in FY24 and Furlenco in FY25 came with integration pains — and the company admits the real cost savings will only “fully reflect in Q3FY25.” Translation: “We’re still unpacking.”
4. Financials Overview
Source table
Metric (₹ Cr)
Q2FY26
Q2FY25
Q1FY26
YoY %
QoQ %
Revenue
875
812
821
7.7%
6.6%
EBITDA
87
70
75
24.3%
16%
PAT
14.4
20.0
6.6
-27.8%
118%
EPS (₹)
0.89
1.83
0.60
-51.4%
48%
Annualized EPS = ₹3.56 ⇒ P/E ≈ 201x (Please remove all sharp objects before reading).
Despite revenue inching up, profit dropped 28% YoY, because foam margins are melting faster than butter in Chennai. EBITDA margins stayed under 10%.
That 200x P/E ratio? It’s what happens when markets believe “Sleepwell” can someday turn into “Profitwell.”
5. Valuation Discussion – Fair Value Range (Educational Only)
